ARTICLE | Clinical News
Technosphere Insulin System endocrine data
June 20, 2005 7:00 AM UTC
In a 12-week, double-blind, placebo-controlled, U.S. trial in 119 patients from the intent-to-treat population, inhaled Technosphere Insulin (TI) plus oral therapy significantly reduced HbA1C levels f...